NCT00002940View on ClinicalTrials.gov

Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 1996

Primary Completion Date

March 31, 2002

Study Completion Date

March 31, 2002

Conditions
Lymphoma
Interventions
DRUG

hydroxyurea

Trial Locations (2)

71130-3932

Louisiana State University Health Sciences Center - Shreveport, Shreveport

38105-2794

Saint Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER

NCT00002940 - Hydroxyurea in Treating Patients With Epstein-Barr Virus-Associated Primary CNS Lymphoma and AIDS | Biotech Hunter | Biotech Hunter